Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bernardo Gradin Will Head Braskem

Predecessor José Grubisich will join parent company Odebrecht's bioenergy business

by Marc S. Reisch
July 7, 2008

Brazilian chemical maker Braskem has appointed Bernardo Gradin as CEO. He replaces José Carlos Grubisich, who led the firm during the past seven years in its efforts to consolidate Brazil's complex petrochemical industry. Grubisich will now head ETH Bioenergia, a year-old bioenergy firm owned by Braskem's controlling shareholder, the Odebrecht Organization.

Since 1987, Gradin, a civil engineer with an M.B.A. from the Wharton School of the University of Pennsylvania, has worked for Odebrecht in a variety of positions. He most recently led Odebrecht Investments & Infrastructure and was at one time head of polyvinyl chloride maker Trikem, one of the companies that merged into Braskem. Gradin also played a role in the development of Braskem's strategic vision and was vice president of two of the firm's business units.

Braskem says Gradin's mission will be to continue the firm's goals to become one of the world's top 10 petrochemical firms, in terms of stock market value, by 2012. Last year, the firm acquired the petrochemical assets of the Ipiranga Group and control of the Copesul ethylene cracker.

Grubisich had led Braskem since its formation in 2002, when Odebrecht and Brazilian chemical player Mariani combined their petrochemical feedstock and downstream vinyl and polyolefin assets. Grubisich joined Braskem from Rhodia, where he was president of the fine organics business and its Latin America unit. He was largely responsible for Braskem's rapid sales growth.

In 2002, Braskem had $2.5 billion in sales, and earnings before taxes and interest stood at $598 million. Last year, the firm had sales of $9.8 billion and earnings before taxes and interest of $1.6 billion.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.